Conversation with Future Clinical Cytogeneticists: The New Frontiers
Genes · 2026
DOI: 10.3390/genes17020232 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Genes, 2026. Verfasst von Jing Christine Ye und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Medicine, Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Hauptthemen laut MEDLINE: Cytogenetics, Cytogenetic Analysis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 142 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The post-genomic era has transformed medical genetics, raising renewed debate over the role of medical cytogenetics in clinical practice. High-throughput sequencing and chromosomal microarray technologies now dominate cancer diagnostics, prenatal testing, and rare disease evaluation by enabling rapid detection of gene-level variation, often leading to the perception that cytogenetics is obsolete. However, this view overlooks the unique and complementary strengths of cytogenetic analysis. Although the relationship between cytogenetics and current NGS technologies can be compared to that between forests and trees versus leaves—both of which are necessary for clinical diagnosis—cytogenetic methods uniquely enable direct in situ visualization of chromosomes, allowing detection of large-scale structural and numerical genome alterations at the level of individual cells and cell populations. These system-level features that are frequently invisible or difficult to interpret using sequencing-based approaches alone yet are critical in disease contexts where genome architecture itself carries biological and clinical significance beyond individual genes. This article, therefore, advances a new perspective based on Genome Architecture Theory: that karyotype-level information organizes gene-level function and that many previous gene-centric genetic concepts require reexamination within a unified framework of clinical genomics. Rather than being replaced, cytogenetics is increasingly integrated with sequencing within a unified framework of clinical genomics that combines high-resolution molecular detail with system-level insight into genome organization. Reassessing the role of cytogenetics, therefore, has important implications for medical education, diagnostic strategy, and healthcare policy, as cytogenetics provides the appropriate platform for understanding system-level inheritance through karyotype coding and for advancing molecular medicine from a genome systems perspective.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cancer Medicine, Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
- Center for Molecular Medicine and Genetics, Wayne State University School of Medicine, Detroit, MI 48201, USA.
- Department of Pathology, Wayne State University School of Medicine, Detroit, MI 48201, USA.
ORCID-Profile: Henry H Heng
Zitieren
APA
Ye, J. C., Chowdhury, R., & Heng, H. H. (2026). Conversation with Future Clinical Cytogeneticists: The New Frontiers. Genes. https://doi.org/10.3390/genes17020232
Vancouver
Ye JC, Chowdhury R, Heng HH. Conversation with Future Clinical Cytogeneticists: The New Frontiers. Genes. 2026. doi:10.3390/genes17020232
BibTeX
@article{Ye2026,
author = {Ye, Jing Christine and Chowdhury, Rishi and Heng, Henry H},
title = {Conversation with Future Clinical Cytogeneticists: The New Frontiers},
journal = {Genes},
year = {2026},
doi = {10.3390/genes17020232}
}
EUVIMED